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THE HYPOPHYSIS AND RESISTANCE TO INTOXICATIONS,
INFECTIONS AND TUMORS*
BY BERNARDO A. HOUSSAY, M.D.\s=d\
Introduction
IN the early days of the study of endocrineglands it was thought that they possessed
antitoxic functions. The disorders due to gland-
ular insufficiency were attributed to toxins
arising from metabolic processes, or absorbed
from the intestine. The toxins were thought to
accumulate in the body because of the fact
that they were neither destroyed in the gland
itself, nor neutralized in the blood or tissues by
the glandular secretions. This antitoxic theory
has deservedly collapsed, since the supposed
toxins have not been isolated, nor has their ex-
istence been demonstrated in a way that would
explain the functional disorders of the different
glandular insufficiencies. On the other hand,
several hormones are now known, and some have
been isolated in a pure state. These hormones
prevent or cure the metabolic and other func-
tional symptoms of the respective glandular de-
ficiencies and, if given in excess, even produce
signs of glandular hyperactivity.
The abandonment of the idea of an antitoxic
function of the endocrine glands in favor of a
hormonal function, has resulted in a loss of in-
terest which reigned about a quarter of a cen-
tury ago, in the study, of the relation between
the endocrine glands and immunity. Never-
theless this problem is of importance both in
general pathology and immunology.
Very little work has been done on the pitui-
tary from this point of view; probably because
there are not many who have access to hypoph-
ysectomized animals, and also because it has
been only recently that active extracts have
been obtained, even though these latter are still
very impure and complex.
The pituitary may play a part in immunity
and resistance to intoxications in various ways:
(1) By direct antitoxic action (intra- or extra-
glandular). (2) By its action on other endo-
crine glands. Since the anterior pituitary reg-
ulates the thyroids,4: adrenal cortex,i gonads,
parathyroids,! etc., the activity of these organs
is decreased in pituitary insufficiency and in-
creased when this gland is overactive. (3) By
action on the hematopoietic or phagocytic or-
gans, e.g., the spleen,4; thymus,4; etc. (4) By
affecting metabolism and vasomotor reactions,
the pituitary influences the resistance of the
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body to agents which lower the blood sugar
and to those which lower the blood pressure.
The action of such agents is intense in hypoph-
ysectomized animals. Por the first of these
mechanisms there is no proof, but the second,




Extirpation and destructive diseases of the
pituitary produce an experimental or pathologi-
cal deficiency in those functions which are di-
rectly performed by the gland. This deficiency
is compensated for or may even be over-com-
pensated for by restitution (implantation of
the gland or injection of extracts). Hyperfunc-
tion (experimental or pathologic) produces op-
posite and different symptoms from those of
glandular insufficiency. When the action is in-
direct, through the effect on another gland
(e.g., thyroid, adrenal cortex, etc.), disturbances
occur which are common to pituitary insuffi-
ciency and to insufficiency of the said gland.
These disturbances are corrected both by prep-
arations of the affected gland (thyroid, adre-
nal cortex, etc.) and by extracts of the pituitary
which are capable of stimulating the gland
(thyrotropic, adrenotropic, etc., pituitary ex-
tracts). The last-mentioned extracts are effec-
tive only when the respective gland is present
and capable of responding to stimulation.
Specific neutralization of toxins or destruc-
tion of germs by the pituitary or its secretions
has not yet been proved. There are, however,
several ways in which it could take a part in
immunity. Thus it might increase the general
resistance of all the body cells or perhaps of
only certain tissues to harmful agents; it might
also enhance the capacity for antibody forma-
tion, or for the fixation and destruction of germs
and toxins. Up to the present it is only pos-
sible to say that endocrine glands appear to play
a certain role in immunity in an indirect way,
by means of their metabolic functions or other
nonspecific activities, such as stimulation of
phagocytosis, or maintenance of the integrity
and resistance of the skin, the mucous mem-
branes, etc. i
THE PITUITARY IN INFECTIONS AND INTOXICATIONS
Infective Lesions of the Pituitary.
The pituitary may be the site of infectious
lesions13, 14- 17, 18> 28, 2S- 33- 3S- 47, 48, 65, 58, B9, e2- 68>
69, 70, 78, etc. sue}j as septic infarcts and abscesses,
which in their ultimate evolution give rise to
atrophy or fibrosis, the appearance of the syn-
dromes of pituitary insufficiency and to Sim-
monds' hypophyseal cachexia.1,18,38,6S'etc- Cir-
i cumscribed tuberculous lesions affecting the
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pituitary as well as metastatic lesions from dis-
tant foci and invasion from neighboring tissues
have been described.1'6'10,20,2S-36,42,44, 48, 60, "• 
52, 54, 63, 64, 68, 69, 74, 77, 84, 88, etc Syphilis1' 8' 9' 10,
15, 21, 22, 24, 30, 32, 37, 45, 46, 48, 49, 51, 60, 62, 65, 67, 68,
69. 73, 75, 80, 81, 82, 83, 85, 87, etc. may produCe gUm-
matous or fibrous lesions in the adult and con-
genital lesions in children. The Treponema pal-
lidum has been found in the latter. (Duperie,
Sabrazes.) Echinococcus31,40,72 and cysticer-
cus1'49 infections of the pituitary have also been
known to occur. Por further details the arti-
cles of Kraus2 and Berblinger1 should be con-
sulted.
The Pituitary in Human Infections.
The pituitary has been studied macroscopi-
cally and-, what is more important, microscopi-
cally in various general infections in human
beings, such as tuberculosis,19,26,48,56-65, "•79, et0-
typhoid,25,28,41, "• 79,et0- diphtheria,16, 23, 28, 35,48,
56.79, etc smallpox,77, etc- erysipelas,77, etc- scarlet
fever,66, et0- tetanus,77,79, etc- the septicemias,11,19,
77,79, etc. intestinal obstruction,77, etc- pneumonia,
25.28, --, 79, etc. rabies,67 typhus,77,79, etc- enceph-
alitis lethargica,41 bronchopneumonia,25,28, 77 and
also in distemper in dogs.24. The older obser-
vations were made with imperfect staining tech-
niques and it was believed that in acute infec-
tions an initial hyperactivity,25, T9 followed later
by exhaustion and hypoactivity (Delille) oc-
curred while in chronic infections there was only
hyperactivity. The cytological changes have been
described more accurately by more recent work-
ers.
Modifications of the Pituitary in Experimental
Infections and, Intoxications.
A number of descriptions have been given of
the histological changes occurring in the pitui-
tary of animals which had been subjected to
various experimental procedures. The proce-
dures used included the following: inoculation
with diphtheria bacilli or toxins,4,16,39,77,86, etc-
typhoid bacilli,77 staphylococci,11 streptococci11
and tubercle bacilli,11 also with the toxins of
worms12,71, etc- and with eel-serum ;39 ligature of
the common bile duct,39 the intestine39 and the
ureter;39 injection of pilocarpine;39,77, etc- alco-
holic poisoning66 and production of uremia.
1, 25, 39, 54, 56, 76, 77, etc. goMy Qn the bagis of
interpretations of the histological changes, it hasbeen supposed that there is an initial hyper-activity leading to exhaustion and functional
insufficiency.
Functional Changes of the Pituitary DuringInfections.
The functional changes in the pituitary dur-
ing infections and intoxications are not accu-
rately known, since no method is available bywhich the pituitary secretion can be measured
in the blood; neither has the relation between
the histological aspect of pituitary glands and
their activity, as demonstrated by implantation
or by injection of extracts made from them, beeninvestigated. Del Castillo, in unpublished
work, found that there was no change in the
gonadotropic effect of the pituitary of rats in-
oculated with Trypanosoma equiperdum on the
immature ovary. The animals were killed eight
to twelve days after inoculation with a strain
that killed the majority of inoculated rats in ten
to twelve days.
Azam7 and Delille,25 pupils of Renon, attribute
the tachycardia, hypotension, insomnia, an-
orexia, sweating, etc., of acute infections to pi-
tuitary insufficiency, although it is by no means
certain that these are the symptoms of such in-
sufficiency. The fact that pituitary extracts
produce some rise in blood pressure, strength-
en the beat and slow the rate of the heart, in-
crease diuresis, etc., is not enough proof to sup-
port their theory.
It has been thought possible that the exag-
gerated increase in height of young typhoid
convalescents might be due to pituitary hyper-secretion,11, 24 though, of course, it might also
be due to the direct action of the typhoid bacilli
or of their products on the cartilage. Sometimes
tuberculous children grow very rapidly whenthey reach adolescence and show signs of prog-nathism, but it has not been shown whether
these symptoms can be attributed to hyperpitui-tarism or to a toxic action of the disease on tissue
growth.34,63 Neither can it be affirmed that the
sexual retardation and amenorrhea of tubercu-
lous adolescents are due to overactivity of the pi-
tuitary.53
RESISTANCE OF HYPOPHYSECTOMIZED ANIMALS TO
INFECTIONS AND INTOXICATIONS
Sensitivity to Anesthetics and Hypnotics.
Chloralose anesthesia is not well tolerated by
hypophysectomized dogs.153 In 1932 we started
to use ether instead of chloralose and the mor-
tality in the first week after operation dropped
from 75 per cent to 15 per cent. On the other
hand it is necessary to use a larger dose of
chloralose than the usual one to anesthetize
hypophysectomized or thyroidectomized dogs
which have been previously treated with thy-
roid (1 to 4 Gm. daily of bovine extract for
four to six days). This is also true in the case
of hypophysectomized dogs after treatment
with anterior pituitary thyrotropic extract.
Ether anesthesia, however, gives unsatisfactory
results in hypophysectomized toads.
The hyperglycemia due to morphia is less
marked in hypophysectomized toads than in
the controls, and implantation of the glandular
lobe increases it.139 In the hypophysectomized
dog this hyperglycemia is on the average higher
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than in the controls, but the difference is not
statistically significant.115 Ten hypophysecto-
mized dogs presented similar symptoms to those
seen in twenty controls when given a subcuta-
neous injection of 30 Mgm. per Kgm. of mor-
phine chloride; one hypophysectomized animal,
however, died two hours later in deep coma,
while another had convulsions and respiratory
failure, but was saved by artificial respiration.
These two animals were the only ones which had
practically no rise in blood sugar. Diabetogenic
anterior pituitary extract increases the hyper-
glycemia due to morphia in dogs.139
Sensitivity to Operations.
Tadpoles deprived of the buccal pituitary
anlage have a diminished resistance to unfavor-
able conditions.89 Hypophysectomized toads,
and those whose glandular lobe alone has been
removed, remain active and appear to be in good
condition for about three weeks after the oper-
ation. Soon after this they become asthenic and
this disturbance increases progressively until
death occurs.132 In spite of their apparent good
health, from the very beginning they are killed
by many operations (e.g., on the testes, thy-
roids, adrenals and even cloacal ligature),
which are well tolerated by the con-
trols.133, 142,167, etc- If, however, these operations
are performed five to ten days before the hy-
pophysectomy many animals survive.
Smith193 stated, and it has been confirmed,
that hypophysectomized rats present a general
physical impairment, characterized by a low-
ered resistance to operative procedures, al-
though the wounds heal well.192 Hypophysec-
tomized rabbits also have a diminished resistance
to surgical trauma.186,18S
Hypophysectomized dogs are very sensitive
to injuries, exposure and bad feeding. They
readily become anorexic, which leads rapidly
either to cachexia or death in hypoglycemia.
100,135 Nevertheless with care a large number
can be kept alive, even after the removal of one
or more other glands besides the pituitary (e.g.,




animals, which have less hyperglycemia, glyco-
suria, azoturia and acidosis, live longer than
the pancreatectomized animals with the pitui-
tary intact, in which the diabetes is more in-
tense. In the former group, with an attenuated
diabetes, the wounds suffer less from infection
and heal, even though no insulin treatment is
given, but they never do so well as the hypoph-
ysectomized animals with the pancreas intact.
Sensitiveness to Infections.
According to Aschner90 hypophysectomized
dogs have a diminished resistance to infections,
being particularly sensitive to mange, and
Cushing106 also states that hypophysectomized
dogs are more susceptible to infections and that
their resistance is diminished. We have not con-
firmed this increased susceptibility having found
that mange is readily cured by sulphur,141 but
we have noted that when infected or ill these
dogs readily become anorexic, hypoglycemic or
cachectic and die. The wounds of hypophysec-
tomized toads (or those without the glandular
lobe) are more readily infected and heal slowly
and with difficulty (Magdalena, Aubrun, Pas-
qualini, etc.). Also, their cutaneous glands are
frequently invaded by cocci (Aubrun and Porto,
unpublished). Hypophysectomized rats show
the same sensitivity to caries of the molars as
do the normal animals.191
Cushing106 described acute or infectious proc-
esses as occurring in seven of his patients, nota-
bly in those with a primary hyperpituitarism.
There also seemed to be a definite susceptibility
to infection in his cases of pituitary basophil-
ism.210 Atkinson6 found that out of 1319 pub-
lished cases of acromegaly only twenty had tu-
berculosis as well, and that six of these died of
the infection.
Sensitivity to Intoxications.
There are four groups of toxic agents which
are poorly tolerated by hypophysectomized ani-
mals, namely, anesthetics, blood sugar reducing
agents, blood pressure reducing agents and
those agents which have intense adverse effects
on thyroidectomized or adrenalectomized ani-
mals.
Blood Pressure Lowering Agents.
The hypersensitivity to histamine and to
other shock inducing agents pertains to this
group.
Amphibians. Removal of the pituitary does not
alter the sensitivity of the frog (Leptodactylus
ocellatus) to veratrine,134 or of the toad (Bufo
arenarum Hensell), twenty days after the oper-
ation, to morphine, atropine, curare, and vera-
trine.124
Rats. Three or more weeks after hypophysec-
tomy in the rat the toxic dose of cobra venom
is only two-thirds of that necessary to kill the
controls.93 The minimum lethal dose of hista-
mine is halved if the hypophysectomy is total
and there is an initial hypotension, but is un-
changed if only the posterior lobe has been re-
moved and there is no hypotension.196 According
to Perla181 the toxic dose of histamine for hy-
pophysectomized rats (one to ten weeks after
operation), which show atrophy of the internal
part of the adrenal cortex, may be one third,
or even only one fifth of that for normal rats.
When a sufficiently large part of the anterior
lobe is left there is no alteration in the adrenal
cortex or in the sensitivity to histamine. Perla
believes that the increased sensitivity is due to
hypofunction of the adrenal, particularly as
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treatment with cortin increases the resistance
to histamine, although it does not modify the
adrenal atrophy.
Putnam182 found that a dose of glycine which
did not affect the controls caused a decreased
metabolism and death in six to twelve hours
in hypophysectomized rats.
Dogs. Ferrer Zanchi118 injected several dogs
with a suspension of dead typhoid bacilli. The
eight controls survived, but two out- of six hy-
pophysectomized animals died, one an hour after
receiving 2,500 million bacilli per Kgm., the
other twenty-four hours after receiving 500
million per Kgm. This is not surprising since
hypophysectomy in the dog produces a slight
lowering of blood pressure and a slower recu-
peration of the normal blood pressure level after
bleeding.101 This slight hypotension has been
observed in the rat196 and is much greater in
the toad.177 Braier100 noted that injections of
B. Coli vaccine caused a less marked rise of the
basal nitrogen and creatinin excretion in hy-
pophysectomized dogs, than in the controls, but
the rise of temperature was similar in both
groups.
Agents Acting Through the Thyroid.
Anterior pituitary extracts, through their
thyrotropic action, cause great sensitivity to an-
oxemia in rats, guinea pigs,146 and mice.190 This
sensitivity is not observed when the thyroids
have been previously extirpated.146 It may be
remarked that hypophysectomized rats tolerate
anoxemia more or less as the normal animals
do. (Chiodi and Rietti, unpublished.)
The fall in body temperature provoked by
novocaine is reduced or prevented in guinea-
pigs,100 and anesthesia by chloralose is some-
what impeded in the dog, by treatment with
thyrotropic pituitary extract.
It is known that the resistance of the white
rat to the toxic action of acetonitrile is increased
by the ingestion of thyroid. (Reid Hunt's ef-
fect.) Injections of thyrotropic preparations
of the anterior pituitary lobe produce a similar
effect,173,176,178, 179,190* because they stimulate
the thyroid to greater activity. This effect of
anterior pituitary extracts has not been ob-
served in thyroidectomized animals.178,17° The
serum of men176 and dogs125 after treatment
with anterior pituitary lobe increases the resist-
ance of rats to acetonitrile, but the serum is
without effect in the absence of the -thyroid.
Oehme, Paal and Kleine176 believe that the ac-
tive substance is other than the thyrotropic
principle of the anterior pituitary, for it ap-
pears to be active per os, and does not cause
histological changes in the thyroids. Posterior
pituitary extract also increases the resistance
*Rietti could not confirm this, but his mice reacted very
irregularly to acetonitrile.
to acetonitrile, without stimulating the thy-
roids.164
Hypoglycemic Agents.
In 1924 Magenta and I found that hypoph-
ysectomized dogs are very sensitive to the
hypoglycemic action of insulin. Later, with
Biasotti and Braier, we found that in these ani-
mals a number of different agents readily pro-
duce hypoglycemia, with severe symptoms such
as convulsions and coma leading to death. This
can be prevented by early treatment with glu-
cose, posterior pituitary extract or adrenalin,
it being necessary sometimes to repeat the treat-
ment. The hypoglycemia can also be prevented
by treatment with anterior pituitary extract
for two to three days. It should further be
noted that hypoglycemic crises occasionally oc-
cur spontaneously in hypophysectomized ani-
mals, whether the pancreas is present or not.
They are frequent during the secondary fall in
blood sugar which follows the hyperglycemia
of adrenalin during fasting, and are constant
after several days of fasting and also after the
injection of phlorhizin or insulin.
Injection of phlorhizin produces fatal hypo-
glycemia in fasting hypophysectomized dogs135
and in hypophysectomized toads.113 This is pre-
vented by feeding the dogs on a protein or car-bohydrate diet, but not by fat diets.97,184 Treat-
ment with alkaline anterior pituitary extract,
before and during a fast of five to six days, pre-
vents the hypoglycemia and death followingphlorhizin.137 Pasting hypophysectomized dogs,
after adrenalin hyperglycemia, have an accen-
tuated secondary hypoglycemia, giving rise to
hypoglycemic crises.100,162
Aschner90 believed that although hypophysec-
tomized dogs have a diminished resistance to
intoxications, they tolerate subcutaneous injec-
tion of adrenalin better than the controls, since
they do not develop local necroses and they
show a lower glycosuria. Braier100 injected
adrenalin intravenously (0.5 Mgm. per Kilo-
gram in twenty minutes) in fasting hypophy-
sectomized dogs, and found during the first six
to seven hours a slightly larger decrease in the
excretion of nitrogen and urea than in the
controls. There was also a lower hyperglycemia,
with a marked secondary hypoglycemia, which
gave rise to convulsions in three out of five
cases; two of these were saved by treatment, but
the other died during the night. When the
animals were fed, the hyperglycemia was the
same or greater than in the controls. In dogs
and men suffering from pituitary insufficiency,
Lucke162 observed a much greater rise in blood
sugar following "adrenalin, followed later how-
ever by a larger fall and a higher renal thresh-
old. In hypophysectomized rabbits the hyper-glycemia occurs more slowly and is not so great
as in the controls.120,156
The New England Journal of Medicine 
Downloaded from nejm.org at SAN DIEGO (UCSD) on December 26, 2015. For personal use only. No other uses without permission. 
 From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
The extreme sensitivity of hypophysecto-
mized animals to insulin was discovered by us.143
Doses, which in the controls cause very slight
lowering of the blood sugar with no symptoms,
cause an intense hypoglycemia in the hypophy-
sectomized animals, with convulsions and coma
invariably ending in death, unless intense and
repeated treatment is carried out. This ex-
treme sensitivity to the hypoglycemic and toxic
action of insulin has been observed in dogs,94-
95, 109, 117, 121, 123, 143, 148, 155, 162, 164, etc. gg^g 166
monkeys,127 rabbits,104,105,12°- 157, 186, 187, 188 and
man,91, 108, 126, 162, 165, etc- but apparently does
not occur in birds;129 it is also observed in hy-
pophysectomized-pancreatectomized dogs (Regan
and Barnes;183 Houssay, unpublished data). It
does not occur in dogs with severe lesions of the
basal or retro-hypophyseal part of the tuber
cinereum,143 or in rabbits with the midbrain
excised.130
According to Geiling and his collaborators
the sensitivity to insulin is due to deficiency of
the posterior pituitary lobe, but on the basis of
our experiments we attribute it to anterior pi-
tuitary deficiency. Extracts of the posterior
lobe can, to a certain extent, counteract the
hypoglycemia and its severe symptoms in the
dog123,143 and toad,145 though vasopressin may
not be efficacious in the rabbit.105 Animals with
inactivated adrenal medulla, which are hyper-
sensitive to insulin, can also be successfully
treated with posterior lobe extract.122
The protective action of the anterior pitui-
tary lobe extract is very potent, far more so than
that of the posterior lobe extract. It is able
fully to counteract the sensitivity to insulin and
also to raise the resistance both in hypophysec-
tomized and normal toads,146 dogs 114,164* and
rabbits.104 The anterior pituitary extract re-
quires one to two days to increase the resist-
ance,114 and therefore is "not efficacious in ani-
mals already in convulsions and coma.143
This protective action also occurs in thyroi-
dectomized-hypophysectomized animals (di Be-
nedetto, Houssay, etc.). The sensitivity of thy-
roidectomized rabbits and dogs to insulin104
(Houssay, etc.) is greatly increased if hypophy-
sectomy is also performed. For this reason we
can exclude the explanation that diminished re-
sistance to insulin following hypophysectomy
is due to hypothyroidism.
It has been thought that this diminished re-
sistance might be due to adrenal insufficiency,96
because adrenalectomized animals are hypersen-
sitive to insulin,160,161 and in pituitary insuffi-
ciency there is some atrophy of the adrenal cor-
tex. The following objections may be raised
against this theory. Anterior pituitary extract
has a diabetogenic action in pancreatectomized
*The commercial extract used by Lucke, of unknown prepara-
tion, has posterior pituitary lobe properties, i.e., it has an
immediate slight glycemie action which does not occur in the
absence of the adrenals.
toads, in adrenalectomized toads and in dogs
lacking the adrenal medulla. It also protects
these latter from insulin. According to Barnes,
Dix and Rogoff, hypophysectomized animals re-
quire more adrenalin to prevent convulsions
than do those with denervated adrenals. They
interpret this observation as showing that hy-
pophysectomized animals do not liberate adre-
nin during insulin hypoglycemia. On the other
hand, Cope and Marks104 demonstrated that
there is adrenin secretion, for which reason
they believe that the anterior lobe of the pitui-
tary maintains the glycogenolytic action of
adrenin normal.
There are insufficient observations to draw
definite conclusions regarding modifications of
the sensitivity to insulin in the diabetes of
acromegalics. Some authors have observed an
increase in the resistance to insulin,110, 162'168,
195, etc. others have found it the same as in other
diabetics,98, 103, 128, 150, 158, 169, 185, 197, etc- and even
hypersensitivity has been described.169
Our opinion is that in pituitary insufficiency
a hormone is lacking which plays an important
role in carbohydrate metabolism; hypersensi-
tivity to insulin is due to the absence of this
hormone which acts as a stimulating agent for
the production of glucose.
Antitoxic Action of the Extracts.
Much work has been done to find out if pi-
tuitary extracts can neutralize poisons or in-
crease the resistance of animals to these agents,
but the results are not conclusive. Delille112 tried
injecting pituitary extract and various poisons
(potassium arsenate, atropine, mercury cyan-
ide, strychnine, human urine) together and
separately, but obtained no definite results.
Maraiion and Aznar170 state that posterior pi-
tuitary lobe extract prevents the toxic action of
strychnine in the guinea pig, so that convul-
sions and death do not occur. These results have
not been confirmed by our experiments.140
Mariante172 stated that posterior lobe extract
masked the toxicity of morphia, but this also
was not confirmed by our experiments in guinea
pigs and pigeons.131,149
Phagocytosis and Opsonins.
There are a number of scattered observations
on the relation of the pituitary to phagocytosis
and opsonins of which the following may be
mentioned. Carbon dioxide does not produce
leueocytosis in hypophysectomized guinea pigs,but if these animals are treated with pituitary
extract, they respond normally.102 The injec-
tion of extract of horse pituitary causes a tran-
sitory increase in the phagocytic power of the
leucocytes and later a diminution.171 Injection
of hypophysin increases the complement in the
serum.161 Pituitrin lowers the opsonic index
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against staphylococci and tubercle bacilli in rab-
bits.194
Parodi (unpublished work) in our Institute
has found a marked decrease in the phagocytic
powers of the polymorphonuclear leucocytes in
the blood of hypophysectomized dogs; using
Radsma's modified method he found that 50 ±
1.9 per cent of the leucocytes ingested starch in
the controls, but only 20 ± 5.2 per cent in the
hypophysectomized animals. Peritoneal injec-
tion of alkaline extract of anterior lobe greatly
increases phagocytosis, but this cannot be con-
sidered a specific action, as extracts of muscle
and kidney will also do this. It is possible that
the diminished phagocytosis found in hypophy-
sectomized animals is due to hypothyroidism.
Antibody Formation.
Borchardt99 states that injection of pituitrin
raises the agglutinating power of the serum in
animals or men injected with typhoid bacilli.
Cutler,107 however, found an equal formation of
these agglutinins in normal and in incomplete-
ly hypophysectomized guinea pigs, and also an
equal formation of hemagglutinins and hemoly-
sis on injection of chicken erythrocytes. He fur-
ther showed that neither ingestion nor intra-
peritoneal injection of pituitary extract altered
the course of immunization.
Ferrer Zanchi118 in our Institute immunized
four hypophysectomized dogs and five controls
with doses of 2,000 to 5,000 millions of dead
typhoid bacilli per Kgm. of body weight. The
agglutination curves and maximum titres were
similar in both groups.
Savino,189 also in our Institute, immunized
five normal and seven hypophysectomized dogs
with diphtheria anatoxin during twelve weeks.
The individual titres of the sera tested every
two weeks, showed a more rapid immunization
in the hypophysectomized animals, the serum of
which always reached a higher final antitoxic
value. The average was 38 ± 6.1 A. U. for the
hypophysectomized, compared with 26
—
5.5
A. U. for the controls, a difference of 12.3 ± 2.6
A. IT. This may be explained as due to hypo-thyroidism,119 to hypersensitivity, to slower ab-
sorption of the anatoxin, or to general nutri-
tive changes.
In contradistinction to Jungeblut and En-
gle,151 Hudson, Lennette and King147 found that
gonadotropic pituitary extract did not cause
the appearance of any activity antagonistic to
poliomyelitis virus in the serum of monkeys, nor
did it increase the resistance of these animals
to intracerebral inoculation.
THE PITUITARY AND CANCER
Tumors of the Pituitary.—The pituitary fre-
quently is the site of adenomatous prolifera-
tion or of true adenomas of acidophilic, baso-
philic, chromophobic or mixed types, which give
rise to more or less specific symptoms. Malig-
nant adenomas or adenocarcinomas may also
occur. Besides these, angiomas, fibromas, tera-
tomas, adamantinomas, etc., have been found.
There is a special group of tumors known as
tumors of the pituitary canal, which consist of
craniopharyngiomas and teratomas.1,209,210,211-
220, 238, 276, etc. jn addition, metastases from vari-
ous origins occur in the pituitary230,236,238,266,274,280, etc givulg riSe to certain symptoms (poly-uria, etc.). When sarcoma is implanted into
the gland in the rabbit it does not proliferate
as much as in other tissues.227
The Pituitary in Cancerous Patients.
Various histological1, 201, 215, 233, 236, 261, 265, 273,
279, 280, etc. cbanges have been described in the
pituitary gland found at autopsy on cancerous
patients, e.g., increase in the principal cells,233
increase215 or decrease of the basophiles,238 in-
crease in the weight of the gland and in the
number of the eosinophiles,280 signs of hyper-
activity of the anterior lobe, and of hypoactivity
of the posterior.273
In rats with subcutaneous implantation of
tumors, there is an increase and vacuolization
of the basophile cells of the pituitary, with en-
largement of their Golgi apparatus. The changes
are similar to those produced by castration, al-
though the sexual cycle is not affected. If these
pituitary glands are then implanted into im-
mature rats it can be demonstrated that theyhave an increased gonadotropic activity.225 Ifthe cancerous implantation is made into the
uterus there is a larger increase of the eosino-
phile cells of the pituitary and less of the baso-
philes, and the pituitary appears like that of
pregnancy or after the injection of estrin.325
Hypophysectomy and Cancer.
Hypophysectomy before or after implantation
of tumors causes a retardation of their growth
in rats199,262 but does not completely stop it,243,255,209 although it has been observed occa-
sionally that shrinkage occurs and fewer of the
implants take.244,262,263 There are also fewer
metastases, but the resistance of the animals is
diminished.244 In hypophysectomized rabbits
also a diminished growth of implanted sarcoma
has been observed,227 although with partial hy-
pophysectomy tar carcinoma may develop more
rapidly than in the controls.234 Irradiation of
the pituitary with x-rays diminishes the growth
of cancer in rats,203-247 but it has not been
proved that this treatment produces any real
change in the gland.
Gonadotropic Substances in the Urine of Cancer
Patients.
The urine of certain cancer patients will cause
ripening of the follicles in the ovary of imma-
ture rats and mice.198,281, etc- Zondek attributes
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this effect to a substance he calls prolan A.
This occurs in 60 to 80 per cent of cancers of
the female genital apparatus198-*208,212,216,221,222,
28i, etc. a21(j aimost constantly in cases of moles
or chorioepitheliomas.198, 204, 206, 218, 221, 228, 229, 235,
248, 262, 253, 260, 267, 281, etc. Jn the latter there may
be as many as 200,000 to 700,000 rat units per
litre, which is of great diagnostic value.
205,229,24i,etc j^ eases of testicular tumors, par-
ticularly in those of embryonic nature, enor-
mous quantities of gonadotropic substances
occur 200, 214, 216, 218, 226, 228, 277, 281, etc- which are
described as prolan A, but differ from this.
The high content found in moles and tumors
compared with the small amount in the pitui-
tary, leads one to the conclusion that it origi-
nates in the tumors and not in the pituitary;
this is also borne out by the differences in the
action of prolan A and anterior pituitary ex-
tracts.
Carcinogenic Action of Pituitary Extracts.
Hofbauer231 insists repeatedly on the danger
of anterior pituitary extracts, since prolonged
administration in guinea pigs produces hyper-
plasia of the endometrium and precancerous
lesions of the uterine neck. Overholser and
Allen251 also found atypical epithelial prolifera-
tion, and possible metaplasia, which seemed to
be precancerous lesions; other investigators206, etc-
do not admit that these are precancerous.
Action of Pituitary Extracts on Cancer.
Posterior pituitary extracts (pituitrin, etc.)
have no influence on the growth of implanted
tumors or human cancers.203,219,237,267,271,273
With several anterior lobe extracts various re-
sults have been obtained, depending on the in-
jected substances, the type of tumor, and the
rapidity of its growth; in some cases an ac-
celerating effect was observed ;203,219,223,227,2B6,
258,272, etc. j^ 0thers there was no alteration. The
inhibitory action on tumor growth by prolan A
described by both Zondek and Hartoch282 has
received some confirmation,207, 212, 242, 260, 264, etc-
but other investigators have not observed this
effect, or else obtained merely a nonspecific weak-
ening in growth.223,224,232,239,240,278, etc- The dis-
turbing effect on tumor growth in vitro de-
scribed by Reiss and Hochwald,256 Kriesch and
Victorisz240 has not been confirmed.249
GENERAL DISCUSSION
The existence of a direct antitoxic or anti-
infectious action of the pituitary gland or its
secretions has not been proved, but the gland
can modify the resistance of the animal by its
metabolic action, its regulating action on the
thyroid or adrenal and on the vascular or nerv-
ous systems.
The gland can show certain histological
changes during infections or intoxications, but
\
their functional significances are not under-
stood. It has been thought that the increased
growth in typhoid convalescents or sexual re-
tardation and amenorrhea in adolescent tuber-"
culous patients, may be due to functional
changes in the gland but as yet there is no
proof of this.
Anesthetics and hypnotics are not tolerated
well by hypophysectomized animals, and after
operation some species are more susceptible to
infections, poisons of the nervous system (cobra
venom, morphia, chloralose), blood pressure low-
ering agents (histamine, etc.) and blood sugar
lowering agents (insulin, phlorhizin, etc.). Hy-
pophysectomy, because it produces hypothy-
roidism, provokes a decrease in phagocytosis and
accelerated formation of antitoxins (in dogs),
the agglutinin production not being changed.
The thyrotropic hormone of the anterior pitui-
tary, by stimulating thyroid activity, causes hy-persensitiveness to anoxemia in rodents; in the
mouse an increased resistance to acetonitrile and
in the dog a slightly increased resistance to
chloralose occur.
The pituitary can be the site of benign or
malignant new growths, also of metastases. The
structure of the pituitary is modified in pa-
tients suffering from cancer. Hypophysectomy
retards, but does not prevent the growth of
tumors and diminishes the number of implanta-
tions which take; probably this is due to a
metabolic action which should be studied. The
urine of cancerous patients (especially cases of
uterine tumors, moles, testicular tumors) has
a powerful gonadotropic activity. Pituitary ex-
tracts can accelerate the growth of certain tu-
mors. In some cases prolan A has an inhibitory
action but its specificity and its practical im-
portance are doubtful.
REFERENCES ON THE INFECTIOUS LESIONS OF THE
HYPOPHYSIS AND ON THE STRUCTURAL CHANGES
IN THE HYPOPHYSIS IN INFECTIONS AND INTOXI-
CATIONS V
As principal sources of general information the following
three papers are recommended:
1. Berblinger, W.: Handb. Innere Sekretion. 1:910, 1932.
2. Kraus, E. J.: Handb. d. spez. path. Anat. u. Histol.
(Henke. Lubarsch) 8:856, 1926.
3. Simonds, J. P.: Endocrinology and Metabolism 1:796, 1922.
4. Abramow,
.
S.: Virehows Arch. f. path. Anat. 214, 408,
1913.
5. Arnould: These Nancy. 1907.
6. Atkinson, F. R. B.: Acromegaly. London: Bale. 1932.
7. Azam, J.: These Fac. Med. Paris. 1907.
8. Barbacci: Lo Sperimentale 364, 1881.
9. Barthelemy: These Med. Paris. 1919.
10. Beadles, C.: Brit. M. J. 2:1775 (Dec 19) 1896.
11. Bell, W. B.: The Pituitary, a Study of the Morphology, etc.
New York: Wood. 1919.
12. Bedson, S. P.: Compt. rend. Soc. de biol. 7:994, 1913.
13. Benda, C.: Arch. f. Ar.at. u. Physiol. 1900, p. 373.
14. Berblinger, W.: Centralbl. f. allg. Path. u. path. Anat.
44:165, 1928; 50, 1930; Handb. innere Sekretion 1:971,
1932.
15. Birch, Hirschfeld, F. V.: Lehrbuch Anat. Path. 281, 1896;
Handb. innere Sekretion 1:910. 1932.
16. Boehncke, K. E., and Koch, R.: Ztsehr. f. Immunitats-
forsch. u. exper. Therap. 21:1, 1914.
17. Bolsi, D. : Riv. Pat. r.erv. ment. 29:74, 1924.
18. Calder, R. M.: Johns Hopkins Hosp. Bull. 50:87 (Feb.)1932.
19. Caselli, A.: Fisiopatologia della ghiandola pituitaria.
Reggio E., Calderini 1900; Policlinico, 1900.
The New England Journal of Medicine 
Downloaded from nejm.org at SAN DIEGO (UCSD) on December 26, 2015. For personal use only. No other uses without permission. 
 From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
20. Cerise: Rev. neurol. 20:227, 1912.
21. Chiari: Deutsche med. Wchnschr. 39:1662, 1913.
22. Cohn, E.: Virchows Arch. f. path. Anat. 240:452, 1923.
23. Creutzfeld: Jahrb. Hamburg St. Krankh. 1908.
24. Cushing, H.: The Pituitary Body and its Disorders. Phila-
delphia and London: J. B. Lippincott Co. P. 264, 1912.
25. Delille, A.: These Med. Paris, 1909.
26. De Vecchi, B., and Bolognesi, G.: Soc. me'd. chir. de
Bologne. 1905. Rev. Neurol. 14:155, 1906.
27. Da Gradi, A.: Patologia dell'ipofisi. Pavia. 1911.
28. Dialti, G.: Patologia e Chirurgia dell'ipofisi. Siena, Ber-
nardino. 1910.
29. Dominguez, C. M.; Rago, M.; Martinez Olascoaga, D.:
Rev. m«d.' Uruguay 30:413 (Aug.) 1927.
30. Dup«ri«, M.: Presse m6d. 17:496. 1909.
31. Esquirol: Cit. por Davaine. Traits des maladies ver-
mineuses. Paris. 1878.
32. Esser, A. C: Centralbl. f. allg. Path. u. path. Anat. 39:97,
1927.
33. Fahr, Th.: Centralbl. f. allg. Path. u. path. Anat. 33:481,
1922-1923.
34. Fishberg, M.: Pulmonary Tuberculosis. 2: 1932. Phila-
delphia: Lea & Febiger.
35. Forlini, E.: Endocrinol, e. Ratol. costit. 2:303 (Dec.)
1927.
36. Froboese, C.: Centralbl. f. allg. Path. u. path. Anat.
29:145, 1918.
37. Gcldzieher, M.: Verhandl. Deutsch. Path. Ges. 16:281,
1913.
38. Graubner, W.: Ztsehr. klin. Med. 101, 249, 1925.
39. Guerrini. G.: Sperimentale. Arch, di biol. 68:837, 1904;
Centralbl. f. allg. Path. u. path. Anat. 16:177, 1905.
40. Guesnard: J. Prog. Sc Med. 1836.
41. Guizzetti, P.: Giorn. Clin. Med. 1930. Arch. Sci. med. 56,
1930.
42. Heidkamp, H.: Virchows Arch. f. path. Anat. 210:445,
1912.
43. Heslopp: Dublin Quart. J. Med. 1878.
44. Hueter, C.: Virchows Arch. f. path. Anat. 182:219, 1905.
45. Hunter, W.: Pathol. Soc. Tr. London 49:249, 1898.
46. Jaffe, R.: Frank. Ztsehr. Path. 27:324, 1922.
47. Kiyono, H.: Virchows Arch. f. path. Anat. 259:388, 1926.
48. Kraus, E. J.: Handb. d. spez. path. Anat. u. Histol.
(Henke, Lubarsch) 8:856, 1926.
49. Kufs: Ztsehr. ges. Neur. u. Psych. 30:286, 1915-16;
Arch. f. Psych, u. Nervenkr. 39:134, 1904-05 ; Rev. neurol.
13:38, 1905.
50. Kurzak, H.: Ztsehr. f. Tuberk. 34:433 (July) 1921.
51. Lancereaux: Traitg d'Anat. Path. 3:732, 1883; (Troisier,
M. Bull. Soc Anat. 9:25, 1874).
52. Letchworth, T. W.: Brit. M. J. 1:1127 (June 28) 1924.
53. Lisser, H.: Am. Rev. Tuberc. 29:249 (March) 1934.
54. Lucien, M., and Parisot, J.: Rev. Neurol. 17-18:970, 1909.
55. Morandi: Arch. Scienze Med. 28: No. 38, 1904.
56. Farhon, C, and Golstein, M.: Les Secretions Internes.
Paris. 1909.
57. Pirone, R.: Arch. Med. Exper. No. 5:588, 1906; 23:125,
1911.
58. Plaut, A.: Virchows Arch. f. path. Anat. 237:165, 1922.
59. Rokitansky: Quoted by Da Gradi.
60. Sabrazes and Duperie: Gaz. Sc Med. Bordeaux. 1913.
61. Savino, E. : Rev. Soc. argent, de biol. 11:107 (May) 1935.
62. Schaefer, H.: Zentralbl. f. allg. Path. u. path. Anat.30:520. 1919-20.
63. Schlagenhaufer: Virchows Arch. f. Path. Anat. 222:249,
1916.
64. Schmitt. P.: Zentralbl. f. allg. Path. u. path. Anat. 34:466,
1923-24.
65. Schmidtmann, M.: Zentralbl. f. allg. Path. u. path. Anat.
30:3, 1919-20.
66. Sehmiergeld, A.: Arch. Med. Exper. Anat. Path. No. 1:76,
1901.
67. Scholtz, L.: Arch. f. Dermat. u. Syph. 147:509, 1924.
68. Simmonds, M.: Deutsche med. Wchnschr. 40:322, 1914;42:190, 1916; 44:862, 1918; Verh. Deutsch. Path. ges.
7:322, 1914; Virchows Arch. f. Path. Anat. 223:281, 1917;Dermat. Wchnschr. 58:104, 1914.
69. Simonds. J. P.: Endocrinology and Metabolism. 1:786.
Edited by L. F. Barker.
70. Simonds, J. P., and Brandes, W. C.: J. A. M. A. 84:1408
(May 9) 1925.
71. Simonin, P.: These Med. Nancy. 1920.
72. Soemmering and Lancereaux: Traits d' Anat. Path. 3:740,1883.
73. Sokoloff, A.: Virchows Arch. f. Path. Anat. 143:333,1896.
74. Sommer, H.: Ztsehr. f. Laryngol. 2:355, 1909.75. Stroebe, H.: Zieglers Beitr. z. path. 37:455, 1905.76. Tanabe, H., and Tamagawa, C.: Trans. Soc. Path. Japon.23:129, 1933.
77. Thaon, P.: These Med. Paris. 1907.
78. Thorn: Arch. mikr. Anat. 67:632, 1901.79. Torr, O.: La ipofisi nelle infezioni. Pisa. 1903.
80. Triboulet, Ribadeau-Dumas and Harvier: Bull. Soc deP«diat. de Par. 11:177, 1909.
81. Turner: Rev. Neurol. Psych. No. 6:344, 1910.
82. Uthy: Budapest! Oroosi Uysag. 2, 14, 1912.83. Virchow: 1858. Quoted by Kraus. 1926.84. Wagner, E.: Arch. f. Heilk. 1862.
85. Weigert, C: Virchows Arch. f. path. Anat. 65:223, 1875.86. Wiethold, F.: Frankf. Z. Pathol. 27:251, 1922.87. Wood, C. E. : J. A. M. A. 52:700 (Feb. 27) 1909.88. Zenoni, C.: Sperimentale. 67:249, 1913; Pathologica 269,1913.
REFERENCES ON THE RELATION OF THE HY'POPHYSIS
TO SENSITIVITY TO ANESTHETICS, OPERATIONS,
AND INTOXICATIONS
89. Allen, B. M.: Science 52:274 (Sept. 17) 1920.
90. Aschner, B.: Pflugers Arch. f. d. ges. Physiol. 146:1, 1912.
91. Assmann: Klin. Wchnschr. 13:1701, 1934.
92. Aubrun, E. A., and Porto, J.: Quoted by Aubrun, E. A.
Rev. Soe. argent, de biol. 11, 1935.
93. Ball, H. A., and Samuels, L. T.: Proc. Soc. Exper. Biol.
& Med. 30:26 (Oct.) 1932; Am. J. Cancer 16:351, 1932.94. Barnes, B. O.; Dix. A. S., and Rogoff, J. M.: Proc Soc.Exper. Biol. & Med. 31:1145 (June) 1934.95. Barnes, B. O., and Regan, J. F.: Endocrinol. 17:522 (Sept.-
Oct.) 1933.
96. Barnes, B. O.; Scott, V. B.; Ferrill, H. W.. and Rogoff,
J. M.: Proc. Soc. Exper. Biol. & Med. 31:524 (Feb.)1934.
9T. Biasotti, A., and Houssay, B. A.: J. Physiol. 77:81 (Dec.)
1932; Compt. rend. Soc. de biol. 112:497, 1933.
98. Blum, L-, and Schwab, H.: Compt. rend. Soc. de biol.
89:195, 1923.
99. Borchardt: Deutsche med. Wchnschr. 46:533, 1920.
100. Braier, B.: Rev. Soc. argent, de biol. 7:140, 283, 305, 1931;
Compt. rend. Soc. de biol. 107:1195 (July 16) 1931;
108:491, 493. 1932. Tesis Doct. Farmac. Bioquim. 1931.101. Braun Menendez, E.: Rev. Soc. argent, de biol. 8:463
(Aug.-Sept.) 1932; 10:204 (July) 1934; Compt. rend.Soc. de biol. 111:477, 1932; 117:453, 1934; Tesis Fac.
Med. Bs. As. 1934.
102. Ciovini, M.: Arch, di farmacol. sper. 20:38, 321, 1915.
103. Colwell, A. R.: Medicine 6:1 (Feb.) 1927.104. Cope. O., and Marks, H. P.: J. Physiol. 83:157 (Dec 31)1934.
105. Corkill, A. B.; Marks, H. P., and White, W. E.: J. Physiol.80:193 (Dec. 5) 1933.
106. Cushing, H.: The Pituitary Body and its Disorders. Phila-
delphia: J. B. Lippincott Co. 1912.
107. Cutler, E. C: J. Exper. Med. 36:243, 1922.
108. d'Antona, L., and Corbini. G.: Med. Klin. 27:1177, 1931.
109. Daggs, R. G., and Eaton, A. G.: Am. J. Physiol. 106:299
(Nov.) 1933.
110. Davidoff, L„ and Cushing, H.: Arch. Int. Med. 39:751
(June) 1927.
111. Del Castillo y Savino, aun in^dito.
112. Delille, A.: These Fac. Med. Paris. 1909.
113. dl Benedetto, E.: Rev. Soe. argent, de biol. 7:196, 1931;Compt. rend. Soc. de biol. 107:1193 (May) 1931.114. dl Benedetto, E.: Rev. Soc. argent, de biol. 8:578, 1932;
Compt. rend. Soc. de biol. 112:499 (Feb. 10) 1933.115. di Benedetto, El. y E.: In press.
116. Donzello, G., and Venuti, V.: Path. rio. quin. dicin. 3:644,1911.
117. Eaton, A. G., and Daggs, G. R.: Am. J. Physiol. 105:29,1933.
118. Ferrer Zanchi, A. G.: Tesis Fac. Med. Bs. As. En pre-paracion.
119. Frouin, A.: Compt. rend. Soe. de biol. 69:237, 1910.120. Fujimoto, Y.: Folia Pharmacol, japon. 15:10 (Nov. 20)1932
121. Geiling, E. M. K„ and Britton, S. W.: Am. J. Physiol.81:478, 1927.
122. Geiling, E. M. K.; Britton, S. W., and Calvery, H, O.:J. Pharmacol. & Exper. Therap. 36:235 (June) 1929.123. Geiling, E. M. K.; Campbell, D.. and Ishikawa, Y.:J. Pharmacol. & Exper. Therap. 31:247 (July) 1927.124. Giusti, L.: Rev. Asoc. m«d. argent. 34:116, 1921 (Soc. debiol. 2:36) ; Compt. rend. Soc. de biol. 85:312, 1921.125. Grab, W.: Arch. f. exper. Path. u. Pharmakol. 167:313,1932; 168:715; Klin. Wchnschr. 34:1443, 1932.
126. Hantschmann, L.: Deutsches Arch. f. klin. Med. 176:397,1934.
127. Hartman, C. G.; Firor, W. M., and Geiling, E. M. K.:
Am. J. Physiol. 95:662, 1930.
128. Hetzel, K. S.: Lancet 1:440 (Feb. 27) 1926.129. Hill, R. T.; Corkill, A. B., and Parkes, A. S.: Proc. Roy.Soc. London. Ser. B. 116:208 (Nov. 1) 1934.130. Hogler, F., and Zell, F,: Klin. Wchnschr. 12:1719 (Nov. 4)1933.
131. Houssay, B. A.: La accion fisiologica de los extractos
hipofisarios 1918; 2a edic Flaiban Bs. As. 1922.
132. Houssay, B. A.: Rev. Soc argent, de biol. 9:34 (April)1933; Compt. rend, Soc. de biol. 113:472, 1933.133. Houssay, B. A.: Rev. Soc. argent, de biol. 11: 1935;Compt. rend. Soc de biol. 1935.
134. Houssay, B. A.: Rev. Univ. Bs. As. 13:89, 1910; Argent.MM. 8:229, 1910; Trab. Labor. Fisiol. Bs. As. 1:95,1910.
135. Houssay, B. A., and Biasotti, A.: Rev. Soc argent, de biol.
6:326. 1930; Compt. rend. Soc. de biol. 105:126, 1930;Pflugers Archiv. 227:664, 1931.
136. Houssay, B. A., and Biasotti, A.: Bol. Acad. Nac. Medic.
Bs. As. 66, 1933.
137. Houssay, B. A.; Biasotti, A.; di Benedetto, E., and Rietti,C. T.: Rev. Soc. argent, de biol. 8:570, 1932.
138. Houssay, B. A., and Biasotti, A.: Congr. Intern. Biol.Montevideo 1930 ; Arch. Soc. Biol. Montevideo. Supp. Fac.
2:277, 1931; Bol. Acad. Nac. Medic. Bs. As. 467, 1930.
139. Houssay, B. A., and di Benedetto, E.: Rev. Soe. argent.de biol. 8:448, 1932; 9:78, 1933; Compt. rend. Soc. debiol. 91:472, 1932; 94:82, 1933.
140. Houssay, B. A., and Giusti, L.: Semana mid. 559 (Nov.)1916.
The New England Journal of Medicine 
Downloaded from nejm.org at SAN DIEGO (UCSD) on December 26, 2015. For personal use only. No other uses without permission. 
 From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
141. Houssay, B. A., and Hug, E.: Rev. Asoc. m*d. argent.
34:1107 (Nov.) 1921 (Soc. de biol. 2:269) ; Compt. rend.
Soc. de biol. 85:1215, 1921.
142. Houssay, B. A., and Lascano-Gonzalez, J. M.: Rev. Soc.
argent, de biol. 7:248, 1931; Compt. rend. Soc. de biol.
108:131, 1931.
143. Houssay, B. A., and Magenta, M. A.: Rev. Asoc. m€d.
argent. 37:389, 1924; (Soc. de biol. 5:389); Rev. Soc.
argent, de biol. 3:217, 1927; 5:99, 1929: Compt. rend.
Soc de biol. 92:822, 1925; 97:596, 1927; 102:429, 1929.
144. Houssay, B. A.; Mazzocco, P., and Rietti, C. T.: Rev.
de la Soc. argent, de biol. 1:231, 1925; Compt. rend. Soc.
de biol. 93:968 (Oct. 23) 1925.
145. Houssay, B. A., and Potick, D.: Rev. Soc. argent, de biol.
5:66, 1929; Compt. rend. Soc. de biol. 101:940, 1929.
146. Houssay, B. A., and Rietti, C. T.: Rev. Soe. argent, de
biol. 8:53 (April) 1932.
147. Hudson, N. P.; Lennette, E. H., and King, E. Q.: J. Ex-
per. Med. 59:543, 1934.
148. Ichijo, T.: Jap. J. M. Sc. Tr. IV. Pharmacol. 8:85 (Aug.)
1934.
149. Iraeta, D.: Rev. Asoc. med. argent. 24:93, 1916.
150. John, H. J.: J. A. M. A. 85:1629 (Nov. 21) 1925.
151. Jungeblut, C. W., and Engle, E. T.: J. Exper. Med. 59:43
(Jan.) 1934.
152. Kalk, H.: Deutsche Med. Wchnschr. 60:893 (June 15)
1934.
153. Kepinow, L., and Guillaumie, M.: Compt. rend. Soc. de
biol. 115:1564, 1934.
154. Kleine, H. O., and Paal, H.: Arch. f. exper. Path. u.
Pharmakol. 168:147, 1933; Arch. f. Gynak. 154:147, 1933.
155. Kobayashi, K.: Jap. J. M. Sc. Tr. IV. Pharmacol. 5:56,
1931.
156. Kusunoki, G.: Folia endocrin. japon. 3:34, 1927.
157. Kusunoki, G., and Nakamura, K.: Klin. Wchnschr. 13:1832,
1934.
158. Labbe, M.; Escalier, A., and Dreyfus, G.: Ann. de med.
29:222, 1931.
159. Labb£, M,; Escalier, A., and Uhry, P.: Compt. rend. Soc
de biol. 114:890, 1933.
160. Lewis, J, T.: Compt. rend. Soc. de biol. 89:1117, 1923;
Rev. Soc med. argent. 36:611 (Oct.) 1923; (Soe. de biol.
4, 13).
161. Lewis, J. T., and Magenta, M.: Rev. Asoc. m£d. argent.
37:370, 1924 (Soc. de biol.) ; (Sompt. rend. Soc. de biol.
92:821 (March 20) 1926.
162. Lucke, H. : Klin. Wchnschr. 11:1678 (Oct. 1) 1932; Ztsehr.
klin. Med. 122:23, 1932; Klin. Wchnschr. No. 39:1547,
1933; Ergebn. d. Inn. Med. u. Kinder. 46:94, 1934.
163. Lucke. H.; Heydemann, E. R., and Duensing, F.: Ztsehr.
f. d. ges. exper. Med. 91:106, 1933.
164. Lucke, H.; Heydemann, E. R., and Hechler, R.: Ztsehr.
f. d. ges. exper. Med. 87:107, 1933; 88:65, 1933.
165. Lyall, A., and Innes, J. A.: Lancet 1:318 (Feb. 9) 1935.
166. McPhail, M. K.: Proc. Roy. Soc. London. B. 117:45, 1935.
167. Magdalena, A.: Rev. Soc. argent, de biol. 10:411, 1934;
Compt. rend. Soc de biol. 118:489, 1935.
168. Mahler, P., and Pasterny, K.: Med. Klin. 20:337 (March
16) 1924.
169. Marafion, G.: An. de med. int. 1:45 (Jan.) 1932.
170. Marafion, G., and Aznar, C.: Bol. Soc. Espafi. Biol. 302,
1931.
171. Marbe, S.: Compt. rend. Soc de biol. 68:1075, 1910.
172. Mariante, T.: These Fac. Med. Porto Alegre, 1916.
173. Oehme, C, and Paal, H.: Ergebn. d. inn. Med. u. Kinderh.
44:214, 1932.
174. Oehme, C; Paal, H., and Kleine, H. O.: Arch. f. exper.
Path. u. Pharmakol. 171:54, 1933.
175. Oehme, C.; Paal, H„ and Kleine, H. O.: Klin. Wchnschr.
ll':1449 (Aug. 27) 1932.
176. Oehme, C.; Paal, H„ and Kleine, H. O.: Arch. f. exper.
Path. u. Pharmakol. 171:54, 1933.
177. Orias, O.: Rev. Soc. argent, de biol. 10:91, 1934; Compt.
rend. Soc. de biol. 116:894, 1934.
178. Paal, H.: Klin. Wchnschr. 10:2172 (Nov.) 1931.
179. Paal, H„ and Huber, W.: Arch. f. exper. Path. u. Phar-
makol. 162:521, 1931.
180. Parodi, A. S.: Actas. 5 Congr. Argent. Med. Rosario
3:240. 1934.
181. Perla, D.: Proc. Soc. Exper. Biol. & Med. 32:797 (Feb.)
1935.
182. Putnam, T. J.: Areh. Surg. 18:1699 (April) 1929.
183. Regan, J. F., and Barnes, B. O.: Am. J. Physiol. 95:83,
1933.
184. Rietti, C. T.: J. Physiol. 77:92 (Dec) 1932.
185. Sachs, E., and Macdonald, M. E.: Arch. Neurol. & Psychiat.13:335 (March) 1925.
186. Saito, G.: Fol. endocrin. japon. 10:1335, 1934.
187. Saito and Sakamoto.: Quoted by Kusunoki, G. y Naka-
mura, K. 1924.
188. Sakamoto, A., and Saito, G.: Ztsehr. f. d. ges. exper. Med.80:601. 1932.
189. Savino, E.: Rev. Soc. argent, de biol. 11:107 (May) 1935.
190. Schittenhelm, A., and Eisler, B.: Klin. Wchnschr. 11:1092
(June) 1932.
191. Schour, I., and Van Dyke, H. B.: J. Dent. Research 14:69
(April) 1934.
192. Selye, H.; Mortimer, H.; Thomson, D. L., and Collip, J. B.:
Arch. Path. 18:878, 1934.
193. Smith, P. E. : J. A. M. A. 88:158 (Jan. 15) 1927.194. Strubell, A., and Michligk: Zentralbl. f. Bakteriol. (Orig )68:501, 1913.
195. Ulrich, H.: Arch. Int. Med. 41:875, 1928; 43:785, 1929.
196. Wyman, L. C, and turn Suden, C: Am. J. Physiol.
109:115. 1934.
197. Yater, W. M.: Arch. Int. Med. 41:883, 1928.
REFERENCES ON THE RELATION OF THE HYPOPHYSIS
TO CANCER
198. Aschheim, A.: Rev. m«d. german-ibero-am. 2:622, 1929;
Am. J. Obst. Gynec. 19:335. 1930; Die Schwangerschafts-
diagnose aus der Harne etc. 1933, Berlin. J. A. M. A.
104:1324 (April 13) 1935.
199. Ball, H. A., and Samuels, L. T.: Am. J. Cancer 16:351
(March) 1932.
200. Beclere, A.: Presse m6d. 42:1513 (Sept.) 1934.201. Berblinger, W., and Muth, K.: Zentralbl. f. Gyn. 47:1713
(Nov. 10) 1923.
202. Bischoff, F., and Maxwell, L. C.: J. Pharmacol, exper.
Therap. 42:387, 1931.
203. Bischoff, F.; Maxwell, L. C, and Ullmann, H. J.: Science
74:16 (July 3) 1931; J. Biol. Chem. 97 Proc. CII, 1932;
Am. J. Cancer 21:329 (June) 1934.
204. Borras, P. E.: Rev. Soc. argent, de biol. 8:195 (May) 1932;
Semana m«d. 2:1670, 1932; Rev. MM. Rosario 22:91
(March) 1932.
205. Brindeau, A.; Hinglais, H., and Hinglais, M.: Compt.
rend. Soc. de biol. 111:988, 1932; 118:46, 1935; Presse
med. 41:705, 1933; 43:1017, 1935.
206. Busse, O.. and Hbevener: Zentralbl. f. Gynak. 68:1218
(May) 1934.
207. Cannavo, L.: Riforma med. 49:278 (Feb.) 1933.208. Cornil, L., and Escarras, A.: Compt. rend. Soc. de biol.
115:605, 1934.
209. Cushing, H.: The Pituitary Body and its Disorders, Phila-
delphia: Lippincott. 1912.
210. Cushing, H.: Lancet 2:119, 175, 1930; Arch. Int. Med.
51:487 (April) 1933.
211. del Rio Hortega, P.: An. Casa de Salud Vadecilla 5:3,
1934.
212. Engel, P.: Med. Klin. 1790, 1930; Ztsehr. f. Krebsforsch.
41:281, 1934.
213. Erdmann, R.: Proc. Soc. Exper. Biol. & Med. 15:96,1917-18.
214. Evans, H. M.; Simpson, M. E.; Austin, P. E„ and Fer-
guson, R. S.: Proc Soc. Exper. Biol. & Med. 31:21 (Oct.)1933.
215. Ferguson, R. S.: Am. J. Cancer 18:269, 1933; J. A. M. A.101:1933, 1933.
216. Fiessinger, N., and Moricard, R.: Compt. rend. Soc. de
biol. 115:1604, 1934.
217. Fischer-Wasels. B. : Endokrinol. 14:100, 1934.
218. Fluhmann, C. F., and Hoffmann, P. E.: Proc. Soc. Exper.
Biol. & Med. 31:1013, 1934.
219. Fodor, I.; Eros, G., and Kunos, I.: Ztsehr. f. Krebsforsch.
38:1. 1932.
220. Frankl-Hochwart: Wien. Med. Wchnschr. Nos. 27, 28, 29,
1909.
221. Gerber, H.: Rev. Pathol. Comp. 33:273, 423, 507, 1933;
La reaction d'Aschheim-Zondek. Son importance pour
l'endocrinologie et le diagnostic des tumeurs. Monog.
tumeurs Inst. Pasteur. Paris: Lefrancois. 1933.
222. Gostimirovic, D.: Munchen. med. Wchnschr. 78:2108, 1931.
223. Gross, L.: Bull, internat. Acad. pol. Sci. CI. Med. No.7-9-257. 275, 1931; Ztsehr. f. Krebsforsch. 38:289, 1933.
224. Gruhzit, O. M.: Arch. Path. 16:303, 1933.
225. Guyer, M. F., and Claus, P. E.: Anat. Rec. 51:20, 1931;
52:225, 1932; 55:17, 1933; 56:373, 1933; 58:15, 1934;
61:57, 1934.
226. Hady: Zentralbl. f. Gyniik. 55:912, 1931.
227. Hayashi, T.: Trans. Jap. Path. Soc. 20:661, 1930.
228. Heidrich, L.; Fels, E., and Mathias, E.: Beitr. z. klin.
Chir. 150:349, 1930.
229. Heim, K.: Med. Klin. 30:700, 1934; Klin. Wchnschr. 14:166
(Feb. 2) 1935.
230. Heuser: Virchows Arch. f. path. Anat. 90, 9, 1887.
231. Hefbauer, J.: Proc. Soc. Exper. Biol. Med. 27:1011, 1929-30;Klin. Wchnschr. 9:2153, 2108, 1930; 11:1298, 1932; Zen-
tralbl. f. Gyniik. 54:2569, 1930; 56:1032, 1932.
232. Julius, H. W.: Acta brev. neerl. Physiol. 4:74, 1934.233. Karlefors, J.: Ztsehr. f. Krebsforsch. 17:195, 1920.
234. Kawamura, M., and Kamikawa, Y.: Trans. Jap, Path. Soc.
20:670, 1930.
235. Kimbrough, R. A., Jr.: Am. J.- Obst. & Gynec. 28:12,
1934.
236. Kiyono, H.: Virchows Arch. f. path. Anat. 259:388, 1926.
237. Korentchevsky, V.: Compt. rend. Soc. de biol. 83:783,
1920.
238. Kraus, E. J.: Handb. d. spez. path. Anat. u. Histol.
8:856, 1926.
239. Krehbiel, O. F.; Haagensen, C. D., and Plantenga, H.:
Am. J. Cancer 21:346, 1934.
240. Kriesch, L. and Victorisz, K.: Zentralbl. f. Gyniik. 58:2370,1934.
241. Leventhal, M. L., and Saphir, W.: J. A. M. A. 103:668,1934.
242. Ludwig, F., and von Ries, J.: Schweiz. med. Wchnschr.
64:141, 1934; Klin. Wchnschr. No. 3:108, 1935.243. McEuen, C. S. : Proc. Soc. Exper. Biol. & Med. 30:928,1933.
244. McEuen, C. S.; Selye, H., and Thomson, D.: Brit. J. Ex-
per. Path. 15:221, 1934.
245. McEuen, C. S.; Thomson, D. L.: Brit. J. Exper. Path.14:224, 1933.
246. Mann, B. ; Meranze, D. R., and Golub, L.: Am. J. Obst.& Gynec. 25:723, 1933.
The New England Journal of Medicine 
Downloaded from nejm.org at SAN DIEGO (UCSD) on December 26, 2015. For personal use only. No other uses without permission. 
 From the NEJM Archive. Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
247. Maxwell, L. C, and Bischoff, F.: J. Pharmacol. Exper.
Therap. 46:59 (Sept.) 1932.
248. Meyer, R.: Zentralbl. Gynak. 54:430, 1930.
249. Meyer, O. O.; McTiernan, C, and Aub, J. C. : Endocrinol.
17:363 (July) 1933.
250. Moller, H.: Frankf. Z. Path. 45:571, 1933.
251. Overholser, M. D., and Allen, E.: Anat. Rec. 55:32,
1932-33.
252. Peralta Ramos, A. Jr., and Valentinuzzi, M.: Semana m§d.
2:807 (Sept.) 1933.
253. Purge, G.; Kese, G., and Coja, N.: Compt. rend. Soc. de
biol. 15:1701 (Feb. 28) 1934.
254. Reiss, M.: Klin. Wchnschr. 12:190, 1933; Med. Klin. 28:992.
1932.
255. Reiss, M.; Druckrey, H., and Hochwald, A.: Klin. Wchn-
schr. 12:1049 (July) 1933.
256. Reiss, M., and Hochwald, A.: Med. Klin. 28:1391, 1943,
1932
257. Riches,'E„ and Kremer, M. : Brit. M. J. No. 3:877, 1932.
258. Robertson, T. B.: J. Exper. Med. 23:631, 1916; Endocrinol.
1:24, 1917.
259. Robertson, T. B., and Burnett, T. C.: J. Exper. Med.
21:280, 1915; J. Cancer Research 3:75, 1918.
260. Rossler, H.: Ztsehr. f. Geburtsch. Gyniik. 96:516, 1929.
261. Saenger, H.: Munchen. Med. Wchnschr. 59:2139, 1912.
262. Samuels, L. T.. and Ball, H. A.: Am. J. Cancer 23:801,
1935.
263. Samuels, L. T., and Ball, H. A.: Am. J. Cancer 18:380,
1933.
264. Savignoni, F.: Rassegna Clin. Ter. Scien. Afflni 11:349,
1933.
265. Schmincke: Monatschr. f. Geburtsh. u. Gynak. 39:839,
1914.
266. Schupfer, F.: Rev. neurol. 6:853, 1898.
267. Schwalm, H. : Zentralbl. f. Gynak. 58:1212, 1934.
268. Sciesinski, K.: Bull, internat. Acad, polon. sc. et d. lett.
CI. med. 225 (Oct.-Dec.) 1931. Bull. IV.
269. Selye, H.; Mortinaer, H.; Thomson, D. L., and Collip, J. B.:
Arch. Path. 18:878, 1934.
270. Simmonds, M.: Munchen med. Wchnschr. 60:127, 1913.
271. Stewart, W.: Brit. M. J. 2:98, 1932.
272. Sugiura, K., and Benedict, S. R.: Am. J. Cancer 18:583,
1933.
273. Susman, W.: Brit. M. J. 2:794 (Oct. 31) 1931.274. Thoinot, and Delamare, G.: Arch. Med. Exper. Anat. Path.
16:128, 1904.
275. Vassitiadis, H.: Compt. rend. Soc. de biol. 115:1241, 1934.
276.'Verga, G.: Patologia Chirurgica dell'ipofisi. Pavia. 1911.
277. Weinstein, G. L., and Schofield, F. S.: Proc. Soc. Exper.
Biol. & Med. 29:852, 1932,
278. Wiesner, B. P., and Haddow, A.: Nature 132:97 (July)1933.
279. Wohlwill. F.: Deutsche Ztsehr. Nervenh. 105:62, 1928.
280. Wyeth, G. A.: Endocrinol. 18:59, 1934.
281. Zondek. B.: Chirurg. 2:1072, 1930; Zentralbl. f. Gyniik.54:2306, 1930; Klin. Wchnschr. 9:679. 1930; 9:1207, 1930;
11:274, 1932; Rev. med. german.-ibero-am. 6:196, 1933.
282. Zondek. H.; Zondek, B., and Hartoeh, W.: Klin. Wchnschr.
11:1785, 1932.
283. Zondek, H.; Zondek, B., and Hartoeh, W.: Klin. Wchnschr.
12:191, 1933.
FOODS CONTAINING ARSENIC AND LEAD
The Department of Agriculture has consistently
maintained that foods containing added arsenic and
lead in amounts held by qualified scientific opinion
to he poisonous or deleterious constitute a definite
menace to public health and, under the pure food
law, are subject to action. As the result of inten-
sive activities over a period of many years the Food
and Drug Administration encounters today relative-
ly few interstate consignments of fruits or fruit by-
products containing dangerous quantities of lead
and arsenic.
The Washington Dehydrated Food Company was
found guilty in 1933 in the Federal court in Yakima,
Washington, of a violation of the Federal Food and
Drugs Act in shipping in interstate commerce stocks
of apple chops carrying residues of poisonous lead
and arsenical sprays which might render them in-
jurious to health. The firm later marketed apple
chops containing lead and arsenic in amounts
deemed by eminent toxicologists to be capable of
injury to health. One of these shipments involved a
consignment destined for export to France. The
Government instituted seizure proceedings when lead
and arsenic in such amounts were found, taking the
position that the pure food law does not sanction the
practice of making foreign countries a dumping
ground for foods not measuring up to the criteria of
fitness set for our own country. The lower Federal
court in that instance, however, ruled against the
Government, holding that the shipment fell within a
proviso in the food law exempting, under certain con-
ditions, violative shipments consigned to foreign
shores. The court also expressed doubt as to the
deleteriousness of the material.
An outgrowth of this adverse decision was the in-
stitution of a suit for damages by the president of
the Washington Dehydrated Food Company against
administrative officials of the Department of Agri-
culture who, in carrying out their duty, had reported
the facts as to the arsenic and lead content of the
export shipment. The civil suit for damages re-
sulted in a hung jury and is of vital interest to every
consumer since in its larger aspects it involved the
question as to whether a Federal officer, in the dis-
charge of his official duties under the Food and
Drugs Act, can be held personally liable for dam-
ages for reporting facts to his superiors in the event
of an adverse court decision under the Food and
Drugs Act. The action in St. Louis is the most re-
cent chapter in the various legal actions which have
grown out of shipments by the Washington Dehy-
drated Food Company.—Bulletin, U. S. Department
of Agriculture.
COOK PORK WELL TO PREVENT TRICHINOSIS
Reports received by the Department of Agricul-
ture of several recent cases of illness and some
deaths from trichinosis justify a repetition of the
warning to cook pork thoroughly before serving.
The parasites occur in a small percentage of hogs,
which themselves suffer no apparent inconvenience.
But the meat of such hogs, unless well cooked, con-
stitutes a considerable danger to human health.
The assumption that pork which has passed inspec-
tion by a federal organization is safe even when
eaten raw or undercooked is erroneous. There is
no test that will show definitely whether trichinae
are present in a sample of pork, except in some
cases of severe infestation. Certain products that
are customarily eaten without cooking in the home
are given a special processing at federally inspected
establishments, and are free from live trichinae.
Pork products of the kind that ordinarily are
cooked in the home are not processed in meat-pack-
ing establishments, since thorough cooking is a com-
plete safeguard.
When infested pork is eaten by human beings in a
raw or insufficiently cooked state, the trichinae are
set free in the digestive tract where they give rise
to numerous young worms. The latter invade the
muscles, thus causing the painful disease, trich-
inosis, which somewhat resembles typhoid fever,
meningitis, and several other diseases that are char-
acterized by fever. Severe cases of this disease are
likely to result in death.
—
Bulletin, TJ. S. Depart-
ment of Agriculture.
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